Heart rate as a therapeutic target in heart failure?

被引：10
|
作者：
Tavazzi, L [1 ]
机构：
[1] Inst Care Res, Dept Cardiol, Policlin San Matteo, Pavia, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2003年 / 5卷 / 0G期
关键词：
heart rate; heart failure; I-f channel; I-f channel antagonist; ivabradine;
D O I：
10.1016/S1520-765X(03)90003-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A common finding in all clinical trials on heart failure is a negative correlation between heart rate and duration of life. In several studies this was found in both patients taking and those not taking beta-blocker agents. In postinfarct patients increasing mortality with increasing heart rate was found in the absence and in the presence of left ventricular dysfunction. Moreover beneficial effects of neurohormonal modulators were found to be greater in heart failure patients with higher heart rate. Thus heart rate can be considered a target for medical intervention, and therapeutic attempts focused on direct control of heart rate have a good rationale. (C) 2003 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：G15 / G18
页数：4
相关论文
共 50 条
  • [1] Heart rate as a prognostic marker and therapeutic target in acute and chronic heart failure
    Oliva, Fabrizio
    Sormani, Paola
    Contri, Rachele
    Campana, Carlo
    Carubelli, Valentina
    Ciro, Antonio
    Morandi, Fabrizio
    Di Tano, Giuseppe
    Mortara, Andrea
    Senni, Michele
    Metra, Marco
    Ammirati, Enrico
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 253 : 97 - 104
  • [2] Is Heart Rate a Treatment Target in Heart Failure?
    Reil, Jan-Christian
    Boehm, Michael
    CURRENT CARDIOLOGY REPORTS, 2012, 14 (03) : 308 - 313
  • [3] Is Heart Rate a Treatment Target in Heart Failure?
    Jan-Christian Reil
    Michael Böhm
    Current Cardiology Reports, 2012, 14 : 308 - 313
  • [4] Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties
    Dobre, Daniela
    Borer, Jeffrey S.
    Fox, Kim
    Swedberg, Karl
    Adams, Kirkwood F.
    Cleland, John G. F.
    Cohen-Solal, Alain
    Gheorghiade, Mihai
    Gueyffier, Francois
    O'Connor, Christopher M.
    Fiuzat, Mona
    Patak, Athul
    Pina, Ileana L.
    Rosano, Giuseppe
    Sabbah, Hani N.
    Tavazzi, Luigi
    Zannad, Faiez
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (01) : 76 - 85
  • [5] Heart Rate as a Therapeutic Target in Angina Pectoris
    Androulakis, Emmanuel
    Tousoulis, Dimitris
    Papageorgiou, Nikolaos
    Kontogeorgou, Anna
    Briasoulis, Alexandros
    Charakida, Marietta
    Siasos, Gerasimos
    Oikonomou, Evangelos
    Siama, Katerina
    Latsios, George
    Stefanadis, Christodoulos
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (09) : 1562 - 1568
  • [6] Is Heart Rate a Norepiphenomenon in Heart Failure?
    Hensey, Mark
    O'Neill, James
    CURRENT CARDIOLOGY REPORTS, 2016, 18 (09)
  • [7] Management of heart rate in heart failure
    Luis Barisani, Jose
    INSUFICIENCIA CARDIACA, 2019, 14 (03) : 88 - 95
  • [8] Heart rate as a therapeutic target in ischaemic heart disease
    Purcell, H
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 1999, 1 (0H) : H58 - H63
  • [9] Endothelium as a therapeutic target in heart failure
    Drexler, H
    CIRCULATION, 1998, 98 (24) : 2652 - 2655
  • [10] Mitochondria as a Therapeutic Target in Heart Failure
    Bayeva, Marina
    Gheorghiade, Mihai
    Ardehali, Hossein
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (06) : 599 - 610
12345